Effects of the Cc2d1a/Freud-1 Knockdown in the Hippocampus of BTBR Mice on the Autistic-Like Behavior, Expression of Serotonin 5-HT1A and D2 Dopamine Receptors, and CREB and NF-kB Intracellular Signaling

被引：0
|
作者：
Irina I. Belokopytova
Elena M. Kondaurova
Elizabeth A. Kulikova
Tatiana V. Ilchibaeva
Vladimir S. Naumenko
Nina K. Popova
机构：
[1] Institute of Cytology and Genetics,
[2] Siberian Branch of the Russian Academy of Sciences,undefined
来源：
Biochemistry (Moscow) | 2022年 / 87卷
关键词：
/Freud-1 knockdown; 5-HT; serotonin receptor; D2 dopamine receptor; CREB; NF-kB; BTBR mice; autistic-like behavior;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1206 / 1218
页数：12
相关论文
共 50 条
  • [21] Effects on plasma prolactin and corticosterone levels of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties
    Carilla-Durand, E
    Assié, M
    Maraval, M
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S438 - S438
  • [22] Structural analogues of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors
    Homan, EJ
    Kroodsma, E
    Copinga, S
    Unelius, L
    Mohell, N
    Wikström, HV
    Grol, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 1111 - 1121
  • [23] Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice
    Eremin, D.
    Ilchibaeva, T.
    Naumenko, V.
    Kondaurova, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S422 - S422
  • [24] 1-cinnamyl-4-(2-methoxyphenyl)piperazines:: Synthesis, binding properties, and docking to dopamine (D2) and serotonin (5-HT1A) receptors
    Penjisevic, Jelena
    Sukalovic, Vladimir
    Andric, Deana
    Kostic-Rajacic, Sladjana
    Soskic, Vukic
    Roglic, Goran
    ARCHIV DER PHARMAZIE, 2007, 340 (09) : 456 - 465
  • [25] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors
    Newman-Tancredi, A
    Cussac, D
    Audinot, V
    Millan, MJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (06) : 447 - 453
  • [26] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
    Adrian Newman-Tancredi
    Mark S. Kleven
    Psychopharmacology, 2011, 216 : 451 - 473
  • [27] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
    Newman-Tancredi, Adrian
    Kleven, Mark S.
    PSYCHOPHARMACOLOGY, 2011, 216 (04) : 451 - 473
  • [28] Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone
    Gener, Thomas
    Tauste Campo, Adria
    Alemany-Gonzalez, Maria
    Nebot, Pau
    Delgado-Sallent, Cristina
    Chanovas, Jordi
    Victoria Puig, M.
    NEUROPHARMACOLOGY, 2019, 158
  • [29] Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents
    Ye, Na
    Song, Zilan
    Zhang, Ao
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (04) : 437 - 457
  • [30] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792
12345